GlassScriptPhysician profile
Heidi Nichols
NPI 1972501138
$2,344.74
in general payments reported to CMS, 2019-2025
38 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $442 · 2022: $225 · 2023: $568 · 2024: $794 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,441 · Education: $237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.95 |
| Education | $236.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $265.02 | 2021-2025 | Imfinzi, Calquence, Lynparza |
| Amgen INC. | $212.68 | 2021-2023 | Kyprolis, Blincyto |
| Janssen Biotech, INC. | $194.30 | 2021-2025 | Rybrevant, Erleada, Akeega |
| Daiichi Sankyo INC. | $152.24 | 2021-2024 | Enhertu |
| Puma Biotechnology, INC. | $125.75 | 2022-2024 | |
| Genentech USA, INC. | $122.71 | 2022-2024 | Phesgo, Tecentriq, Alecensa |
| Merck Sharp & Dohme LLC | $121.05 | 2021-2024 | Keytruda, Lynparza |
| Abbvie INC. | $95.94 | 2022-2025 | |
| Aveo Pharmaceuticals, INC. | $92.00 | 2025 | |
| Seagen INC. | $91.32 | 2023 | Tukysa |
| Astellas Pharma US INC | $69.67 | 2024-2025 | Xospata, Padcev |
| E.R. Squibb & Sons, L.L.C. | $63.16 | 2021-2024 | Opdivo |
| Takeda Pharmaceuticals U.S.A., INC. | $60.70 | 2024-2025 | Fruzaqla, Iclusig |
| Pfizer INC. | $48.88 | 2023 | |
| Lilly USA, LLC | $48.82 | 2021-2024 | Jaypirca, Verzenio, Retevmo |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Nichols listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.